Literature DB >> 4623702

[Studies on the bioavailability of glibenclamide].

W Rupp, O Christ, W Fülberth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4623702

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  13 in total

1.  Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.

Authors:  S W Coppack; A F Lant; C S McIntosh; A V Rodgers
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 2.  Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors:  Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Behaviour of glibenclamide on repeated administration to diabetic patients.

Authors:  L Balant; G R Zahnd; F Weber; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

5.  Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors:  H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

Review 6.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

8.  Comparison of the pharmacokinetics of glipizide and glibenclamide in man.

Authors:  L Balant; J Fabre; G R Zahnd
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

9.  Drugs acting on SUR1 to treat CNS ischemia and trauma.

Authors:  J Marc Simard; S Kyoon Woo; Sergei Bhatta; Volodymyr Gerzanich
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

10.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.